Showing results (81-90 of 418) with videos related to
Sort By:
Pageof 42
Cancer Medicine|November 22, 2022
On target methods to induce abscopal phenomenon for Off-Target effects: From happenstance to happeningsBlessie Elizabeth Nelson, Jacob J Adashek, Steven H Lin, et al.Current Oncology Reports|October 15, 2017
The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular MicroscopeRoman Groisberg, Jason Roszik, Anthony Conley, et al.Molecular Cancer Therapeutics|June 1, 2023
Predicting the Abscopal Effect: Associated Tumor Histologic Subtypes and BiomarkersBlessie Elizabeth Nelson, Jacob J Adashek, Aakash Akshay Sheth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
State-of-the-Art Strategies for Targeting RET-Dependent CancersVivek Subbiah, Dong Yang, Vamsidhar Velcheti, et al.Cancer Discovery|April 3, 2021
Development of Immunotherapy Combination Strategies in CancerTimothy A Yap, Eileen E Parkes, Weiyi Peng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2023
Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical ImplicationsMohamed A Gouda, Blessie E Nelson, Lars Buschhorn, et al.Journal of Clinical Medicine|June 19, 2024
Deciphering Tumor Response: The Role of Fluoro-18-d-Glucose Uptake in Evaluating Targeted Therapies with Tyrosine Kinase InhibitorsKalevi Kairemo, Mohamed Gouda, Hubert H Chuang, et al.CA: a Cancer Journal for Clinicians|May 30, 2024
The evolving landscape of tissue-agnostic therapies in precision oncologyVivek Subbiah, Mohamed A Gouda, Bettina Ryll, et al.Cell|April 4, 2020
Snapshot: Trial Types in Precision MedicineDane Dickson, Jennifer Johnson, Raymond Bergan, et al.JAMA Network Open|November 12, 2021
Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non-Small Cell Lung CancerSreeram Ramagopalan, Alind Gupta, Paul Arora, et al.Pageof 42